Athena Philis-Tsimikas, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Lilly, Novo, Sanofi, Dexcom, Gan & Lee
    Topic:
    Diabetes and Obesity
    Date added:
    10/10/2026
    Date updated:
    10/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Lilly, Novo, Sanofi, Dexcom, Gan & Lee
    Topic:
    Diabetes and Obesity
    Date added:
    10/10/2026
    Date updated:
    10/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Lilly, Novo, Sanofi, Dexcom
    Topic:
    Diabetes and Obesity
    Date added:
    10/10/2026
    Date updated:
    10/10/2026
Return to The Next Chapter in Insulin Therapy: Harnessing the Clinical Potential of Once-Weekly Basal Insulins in Type 2 Diabetes Practice